Mark S. Gelder
2012 - Heron Therapeutics
In 2012, Mark S. Gelder earned a total compensation of $1.8M as Senior Vice President and Chief Medical Officer at Heron Therapeutics.
Compensation breakdown
| Option Awards | $1,697,600 |
|---|---|
| Salary | $26,923 |
| Other | $40,000 |
| Total | $1,764,523 |
Gelder received $1.7M in option awards, accounting for 96% of the total pay in 2012.
Gelder also received $26.9K in salary and $40K in other compensation.
Rankings
In 2012, Mark S. Gelder's compensation ranked 3,987th out of 11,487 executives tracked by ExecPay. In other words, Gelder earned more than 65.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,987 out of 11,487 | 65th |
Division Manufacturing | 1,381 out of 4,253 | 68th |
Major group Chemicals And Allied Products | 311 out of 1,198 | 74th |
Industry group Drugs | 185 out of 920 | 80th |
Industry Pharmaceutical Preparations | 142 out of 700 | 80th |
Source: SEC filing on May 9, 2013.
Gelder's colleagues
We found three more compensation records of executives who worked with Mark S. Gelder at Heron Therapeutics in 2012.